Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,363 | 19 | 89.2% |
| Food and Beverage | $1,951 | 105 | 5.7% |
| Travel and Lodging | $1,675 | 13 | 4.9% |
| Education | $64.30 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $32,858 | 80 | $0 (2024) |
| ITI, Inc. | $276.32 | 11 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $152.79 | 9 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $139.53 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $126.40 | 7 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $88.13 | 5 | $0 (2021) |
| Corium, LLC | $59.98 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $58.80 | 3 | $0 (2023) |
| Bausch Health US, LLC | $47.43 | 2 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $41.43 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,108 | 27 | ABBVIE INC. ($4,840) |
| 2023 | $15,057 | 43 | ABBVIE INC. ($14,784) |
| 2022 | $8,016 | 34 | ABBVIE INC. ($7,723) |
| 2021 | $5,873 | 36 | AbbVie Inc. ($5,511) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,925.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/05/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Education | In-kind items and services | $12.15 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $38.86 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Neuroscience | ||||||
| 01/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $93.84 | General |
| Category: PSYCHIATRY | ||||||
| 01/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Neuroscience | ||||||
| 01/24/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 34 | 113 | $19,890 | $8,989 |
| 2021 | 2 | 24 | 55 | $12,600 | $4,744 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 99 | $14,850 | $7,410 | 49.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 14 | 14 | $5,040 | $1,579 | 31.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 44 | $8,350 | $3,404 | 40.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 11 | 11 | $4,250 | $1,340 | 31.5% |
About Amanda Thomas
Amanda Thomas is a Psychiatric/Mental Health healthcare provider based in Tupelo, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1902031099.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Thomas has received a total of $34,053 in payments from pharmaceutical and medical device companies, with $5,108 received in 2024. These payments were reported across 140 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,363).
As a Medicare-enrolled provider, Thomas has provided services to 58 Medicare beneficiaries, totaling 168 services with total Medicare billing of $13,733. Data is available for 2 years (2021–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health, Mental Health
- Location Tupelo, MS
- Active Since 05/19/2009
- Last Updated 01/14/2022
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1902031099
Products in Payments
- VRAYLAR (Drug) $32,858
- CAPLYTA (Drug) $415.85
- REXULTI (Drug) $158.82
- INVEGA SUSTENNA (Drug) $152.79
- AUSTEDO (Drug) $88.13
- Azstarys (Drug) $59.98
- TRINTELLIX (Drug) $58.80
- APLENZIN (Drug) $47.43
- ECM Patch,Pouch (Device) $38.96
- NUEDEXTA (Drug) $31.64
- ARISTADA (Drug) $30.90
- Qelbree (Drug) $26.98
- LATUDA (Drug) $16.22
- HETLIOZ (Drug) $15.96
- QELBREE (Drug) $14.45
- QUVIVIQ (Drug) $13.56
- ADHANSIA XR (Drug) $13.09
- JORNAY PM (Drug) $11.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Tupelo
Dawn Begner, Np, NP
Psychiatric/Mental Health — Payments: $2,843
Summer Jennings, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $2,637
Amanda Martin, Fnp, FNP
Psychiatric/Mental Health — Payments: $2,356
Ashley Cooper, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,194
Brandi Moore, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,128
Ms. Jennifer Warren, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,080